Showing results (61-70 of 274) with videos related to
Sort By:
Pageof 28
Thrombosis and Haemostasis|June 8, 2020
Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF ProjectAnny Camelo-Castillo, José Miguel Rivera-Caravaca, Francisco Marín, et al.Cureus|January 30, 2024
Uncommon Find: An Unusual 10 cm Bezold's Abscess Involving Dural and Mastoid ErosionJerry Cruz Rodriguez, Ana L Melero Pardo, Isabel Castellanos Castillo, et al.Thrombosis and Haemostasis|December 7, 2017
Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS TrialMaría Asunción Esteve-Pastor, José Miguel Rivera-Caravaca, Alena Shantsila, et al.Peptides|January 28, 2012
Impact of glomerular filtration rate on urinary BNP and NT-proBNP levels in heart failureRaquel Cortés, Manuel Portolés, Esther Roselló-Lletí, et al.Chemical Society Reviews|August 22, 2020
Spectroscopy, microscopy, diffraction and scattering of archetypal MOFs: formation, metal sites in catalysis and thin filmsMiguel Rivera-Torrente, Laurens D B Mandemaker, Matthias Filez, et al.Journal of Chemical Information and Modeling|November 22, 2011
Comparison of combinatorial clustering methods on pharmacological data sets represented by machine learning-selected real molecular descriptorsOscar Miguel Rivera-Borroto, Yovani Marrero-Ponce, José Manuel García-de la Vega, et al.Critical Reviews in Food Science and Nutrition|January 5, 2021
Novel insights in the relationship of gut microbiota and coronary artery diseasesInmaculada Ramírez-Macías, Esteban Orenes-Piñero, Anny Camelo-Castillo, et al.Journal of Clinical Medicine|August 7, 2021
Prediction of Residual Stroke Risk in Anticoagulated Patients with Atrial Fibrillation: mCARSWern Yew Ding, José Miguel Rivera-Caravaca, Francisco Marin, et al.International Journal of Clinical Practice|December 7, 2020
Outcomes in VKA-treated patients with atrial fibrillation and chronic kidney disease: Clinical trials vs 'real-world'Wern Yew Ding, José Miguel Rivera-Caravaca, Alena Shantsila, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 10, 2022
Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?Lorena Martínez-Montesinos, José Miguel Rivera-Caravaca, Stefan Agewall, et al.Pageof 28